149 related articles for article (PubMed ID: 31286313)
21. Neoadjuvant intraperitoneal chemotherapy followed by radical surgery and HIPEC in patients with very advanced gastric cancer and peritoneal metastases: report of an initial experience in a western single center.
Fava BEC; da Costa WL; Medeiros MLL; Sonagli M; de Castro Ribeiro HS; Diniz AL; Godoy AL; de Farias IC; de Jesus VHF; Begnami MDFS; Coimbra FJF
World J Surg Oncol; 2018 Mar; 16(1):62. PubMed ID: 29566715
[TBL] [Abstract][Full Text] [Related]
22. HIPEC and CRS in peritoneal metastatic gastric cancer - who really benefits?
Hotopp T
Surg Oncol; 2019 Mar; 28():159-166. PubMed ID: 30851894
[TBL] [Abstract][Full Text] [Related]
23. [Dual arterial infusion chemotherapy, continuous hyperthermic peritoneal perfusion, and total parietal peritonectomy for peritoneal dissemination in gastric cancer--a case report].
Fujimura T; Yonemura Y; Fujita H; Kawamura Y; Hasebe K; Kaji M; Nakai M; Ninomiya I; Sahara H; Sugiyama K
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2335-7. PubMed ID: 7944473
[TBL] [Abstract][Full Text] [Related]
24. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP).
Manzanedo I; Pereira F; Rihuete Caro C; Pérez-Viejo E; Serrano Á; Gutiérrez Calvo A; Regueira FM; Casado-Adam Á; Cascales-Campos PA; Arteaga X; García-Fadrique A; Gómez Sanz R; López García A; Zozaya G; Arjona Á; Gil Martínez J
Ann Surg Oncol; 2019 Aug; 26(8):2615-2621. PubMed ID: 31115852
[TBL] [Abstract][Full Text] [Related]
25. [Chemo-hyperthermic peritoneal perfusion for therapy of advanced gastric cancer with peritoneal dissemination].
Ikeguchi M; Kaibara N
Nihon Rinsho; 2001 Apr; 59 Suppl 4():469-72. PubMed ID: 11424427
[No Abstract] [Full Text] [Related]
26. Gene expression changes induced by HIPEC in a murine model of gastric cancer.
Graziosi L; Mencarelli A; Renga B; Santorelli C; Cantarella F; Bugiantella W; Cavazzoni E; Donini A; Fiorucci S
In Vivo; 2012; 26(1):39-45. PubMed ID: 22210714
[TBL] [Abstract][Full Text] [Related]
27. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Dissemination from Small Bowel Malignancy: Results from a Single Specialized Center.
Liu Y; Ishibashi H; Takeshita K; Mizumoto A; Hirano M; Sako S; Takegawa S; Takao N; Ichinose M; Yonemura Y
Ann Surg Oncol; 2016 May; 23(5):1625-31. PubMed ID: 26717938
[TBL] [Abstract][Full Text] [Related]
28. Patients with Peritoneal Carcinomatosis from Gastric Cancer Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Is Cure a Possibility?
Chia CS; You B; Decullier E; Vaudoyer D; Lorimier G; Abboud K; Bereder JM; Arvieux C; Boschetti G; Glehen O;
Ann Surg Oncol; 2016 Jun; 23(6):1971-9. PubMed ID: 26753751
[TBL] [Abstract][Full Text] [Related]
29. Postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy affect long-term outcome of patients with peritoneal metastases from colorectal cancer: a two-center study of 101 patients.
Baratti D; Kusamura S; Iusco D; Bonomi S; Grassi A; Virzì S; Leo E; Deraco M
Dis Colon Rectum; 2014 Jul; 57(7):858-68. PubMed ID: 24901687
[TBL] [Abstract][Full Text] [Related]
30. Should a History of Extraperitoneal Disease Be a Contraindication to Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer Peritoneal Metastases?
Baratti D; Kusamura S; Iusco D; Cotsoglou C; Guaglio M; Battaglia L; Virzì S; Mazzaferro V; Deraco M
Dis Colon Rectum; 2018 Sep; 61(9):1026-1034. PubMed ID: 30086051
[TBL] [Abstract][Full Text] [Related]
31. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy for peritoneal surface malignancy: non-colorectal indications.
Shen P; Stewart JH; Levine EA
Curr Probl Cancer; 2009; 33(3):168-93. PubMed ID: 19647615
[No Abstract] [Full Text] [Related]
32. Combined treatment with surgery and intraperitoneal hyperthermic perfusion (IPHP) for far-advanced gastrointestinal cancer with peritoneal seeding.
Fujimoto S; Shrestha RD; Kobayashi K; Koike S; Kokubun M; Kiuchi S; Takahashi M; Konno C; Okui K
Acta Med Austriaca; 1989; 16(3-4):76-80. PubMed ID: 2609917
[TBL] [Abstract][Full Text] [Related]
33. Cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with gastric cancer and peritoneal carcinomatosis.
Rihuete Caro C; Manzanedo I; Pereira F; Carrion-Alvarez L; Serrano Á; Pérez-Viejo E
Eur J Surg Oncol; 2018 Nov; 44(11):1805-1810. PubMed ID: 30087071
[TBL] [Abstract][Full Text] [Related]
34. Evolution of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Peritoneal Metastases: 8-Year Single-Institutional Experience.
Narasimhan V; Britto M; Pham T; Warrier S; Naik A; Lynch AC; Michael M; Tie J; Ramsay R; Heriot A
Dis Colon Rectum; 2019 Oct; 62(10):1195-1203. PubMed ID: 31490828
[TBL] [Abstract][Full Text] [Related]
35. Reply to "Peritoneal carcinomatosis in patients with gastric cancer and the role for surgical resection, cytoreductive surgery, and hyperthermic intraperitoneal chemotherapy".
Graziosi L; Marino E; Donini A
Am J Surg; 2014 Jul; 208(1):158-9. PubMed ID: 24530090
[No Abstract] [Full Text] [Related]
36. Relation between clinical and histologic outcome of intraperitoneal hyperthermic perfusion for patients with gastric cancer and peritoneal metastasis.
Fujimoto S; Takahashi M; Kobayashi K; Kure M; Mutou T; Masaoka H; Ohkubo H
Oncology; 1993; 50(5):338-43. PubMed ID: 8378028
[TBL] [Abstract][Full Text] [Related]
37. Defining and Refining the Role for Surgery and Intraperitoneal Chemotherapy in the Treatment of Peritoneal Surface Malignancies.
Choudry MH; Bartlett DL; Alexander HR; Turaga KK
Ann Surg Oncol; 2020 Jan; 27(1):73-75. PubMed ID: 31646448
[No Abstract] [Full Text] [Related]
38. Survival benefit of gastrectomy for gastric cancer with peritoneal carcinomatosis: a propensity score-matched analysis.
Geng X; Liu H; Lin T; Hu Y; Chen H; Zhao L; Mou T; Qi X; Yu J; Li G
Cancer Med; 2016 Oct; 5(10):2781-2791. PubMed ID: 27650694
[TBL] [Abstract][Full Text] [Related]
39. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
40. Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases: a randomized phase-II clinical trial with a 40-month follow-up.
Huang O; Lu X; Xu X; Shi Y
Cell Biochem Biophys; 2015 Mar; 71(2):1171-80. PubMed ID: 25398590
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
